The use of rapid onset opioids for breakthrough cancer pain: The challenge of its dosing
Author:
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 80 (3) , 460-465
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Assessment and classification of cancer breakthrough pain: A systematic literature reviewPain, 2010
- Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain ReliefJournal of Pain and Symptom Management, 2008
- Optimization of opioid therapy for preventing incident pain associated with bone metastasesJournal of Pain and Symptom Management, 2004
- Breakthrough pain characteristics and syndromes in patients with cancer pain. An international surveyPalliative Medicine, 2004
- Episodic (breakthrough) painCancer, 2002
- Morphine and alternative opioids in cancer pain: the EAPC recommendationsBritish Journal of Cancer, 2001
- Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)Pain, 2001
- Breakthrough pain: characteristics and impact in patients with cancer painPain, 1999
- Breakthrough pain in cancer patients: Pathophysiology and treatmentCancer Treatment Reviews, 1998
- Breakthrough pain: definition, prevalence and characteristicsPain, 1990